Everything you need to win Muscular Dystrophy Association and Coalition to Cure Calpain 3 — in one platform.
Who to reach, what to say, and why now on Muscular Dystrophy Association and Coalition to Cure Calpain 3 — plus every funding round, exec hire, and M&A move that follows, each with the verified contact and the outreach written for you.
Get the full Deep Dive on Muscular Dystrophy Association and Coalition to Cure Calpain 3 — free.
One free Deep Dive, emailed to you. No spam; unsubscribe anytime.
The decision-maker’s email and mobile — dial in-browser.
Muscular Dystrophy Association and Coalition to Cure Calpain 3 Partner to Fund $300,000 Research Grant for Gene Therapy Development
Dec 17, 2024•over 1 year ago
Contract Type
partnership
New YorkBiotechnologyHealth CareNon Profit
Description
The Muscular Dystrophy Association and Coalition to Cure Calpain 3 have announced a collaborative funding of a $300,000 research grant to support the work of Dr. Melissa Spencer, aimed at developing gene therapy for limb-girdle muscular dystrophy type 2A (LGMD2A/R1). This partnership underlines the importance of collaboration in advancing research for potential cures of neuromuscular diseases.
Company Information
Company
Muscular Dystrophy Association and Coalition to Cure Calpain 3
Location
New York, New York, United States
About
The Muscular Dystrophy Association (MDA) is a nonprofit organization dedicated to finding treatments and cures for muscular dystrophy. The Coalition to Cure Calpain 3 (C3) is an organization focused on research and funding for calpain-3 related diseases.
Predictive Intelligence
Strategic
ML-powered predictions for Muscular Dystrophy Association and Coalition to Cure Calpain 3's next move
New YorkBiotechnologyHealth CareNon Profit